Wellington Management, an investment manager for pensions, insurers, and other firms, has raised $476 million for its second biotech venture fund. The Boston-based firm manages over $1.1 trillion and aims to become a more significant player in biotechnology venture capital.
All the week’s industry events straight to your inbox.
By signing up you agree to our terms of use and privacy policy.
7 Bell Yard, London, England, WC2A 2JR
You will soon receive a Reset Password link
By signing up you agree to terms of use and privacy policy.
Continue with Facebook Continue with Google